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Abstract 
The effect of poly-L-aspartic acid (PA) on the crys-
tal structure of calcium oxalate crystals grown after 
spontaneous nucleation was evaluated as a function of 
relative supersaturation and calcium:oxalate ratio in a 
buffered salt solution, with pH and ionic strength in the 
range of normal human urine. PA was used as a model 
for naturally occurring acidic urine proteins that have 
been shown to inhibit nucleation and growth of calcium 
oxalate crystals. The crystals grown were characterized 
by optical microscopy and X-ray powder diffraction. It 
was observed that calcium oxalate monohydrate was the 
preferred crystalline form in the absence of added PA, 
and it was the only crystalline form obtained at most 
conditions tested without PA. However, the presence of 
PA favored the formation of calcium oxalate dihydrate 
crystals, when present in adequate quantities. The quan-
tity of PA required to affect this change in preferred 
crystal structure was increased at higher supersaturations 
and at lower calcium:oxalate ratios, exhibiting a non-lin-
ear dependence on both variables. PA was also shown 
to be a kine.tic inhibitor of calcium oxalate dihydrate 
crystallization. Aspartic acid monomer was found to 
cause no change in the preferred structure of calcium 
oxalate monohydrate at mass concentrations well beyond 
those required with PA to obtain 100 % calcium oxalate 
dihydrate, indicating the critical importance of the poly-
meric nature of PA for this effect on crystal structure. 
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Introduction 
Conditions affecting the crystallization of calcium 
oxalate (CaOx) in ionic solution are of critical impor-
tance for understanding nephrolithiasis (kidney stone dis-
ease) since CaOx is the dominant species found in these 
pathologic crystals [13 , 14, 17]. One of the principle 
questions in nephrolithiasis is by what mechanism does 
the incipient crystal become trapped in the kidney, form-
ing a symptomatic stone. Given the kinetic limitation to 
stone formation by normal urine flow, a crystal must ei-
ther evolve rapidly through a combination of nucleation, 
growth and aggregation to yield a crystal mass that is 
large enough to become physically trapped in the collect-
ing system or adsorb to the tubular cell surface to allow 
prolonged crystal mass accumulation [4]. CaOx crystals 
are commonly found as either the monohydrate (COM) 
or the dihydrate (COD) structure in patient samples [13 , 
14, 17). The structural difference may play a key role 
in the regulation of nephrolithiasis , although no mecha-
nism for such an effect has yet been established. 
Data from several experiments suggest that COM 
may have a greater tendency to form kidney stones than 
COD. Previous studies of samples from patient have 
shown that kidney stones are predominately COM, al-
though COD crystals are also observed [ 13, 14, 17). 
On the other hand, asymptomatic crystals in the urine 
are usually COD, with COM found in some samples [6]. 
Laboratory experiments have shown that COM does bind 
to inner medullary tubular cell membranes [15, 22), al-
though similar experiments have not been published for 
COD. Other experiments in the same laboratory demon-
strate a stronger biological membrane interaction for 
COM in its g_reater ability to lyse red blood cells com-
pared to COD [21). In addition, theoretical calculations 
of the degree of dimensional matching between crystal 
lattice structures and head (charge) group distributions 
of phospholipid membranes show a greater number of 
matches with COM than with COD crystals [12). These 
varied results argue strongly for the possibility that the 
formation of COD is protective against stone disease, 
and the most likely mechanism for this effect would be 
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reduced cell adhesion to the renal tubular cells. There-
fore, it is important to understand the conditions that 
favor COD formation. 
Recently, there has been a lot of interest in urinary 
molecules that have been shown to inhibit CaOx crystal 
formation [4, 8) and thereby prevent crystal entrapment 
by limiting crystal si:ze. Many of these molecules have 
also been shown to influence the crystal structure, lead-
ing to the formation of COD rather than COM in typical 
ionic solutions. Martin et al. [16) have shown that both 
small molecule and macromolecule inhibitors found in 
urine favor the formation of COD, and the unseparated 
solutes from urine were more effective in this regard 
than any of the single component inhibitors tested. The 
small molecule inhibitors of citrate and pyrophosphate 
accounted for less than half of the effect noted in the 
urine solute samples. The known macromolecules tend 
to be polyanions and are generally acidic in nature [7, 
18). One such macromolecule found in human urine is 
uropontin [18, 24), which has been shown to be an ef-
fective inhibitor of nucleation [23) and growth [24) of 
CaOx crystals. Uropontin (or osteopontin) is a 44 kDa 
protein [3], and occurs in rodent urine at a concentration 
of about 8 µg/ml [5]. It contains 15-20% aspartic acid 
units [5, 18, 24), including a run of 8-10 aspartic acid 
units [5, 24), which is thought to be important to crystal 
surface interactions, possibly in a specific manner [l, 2]. 
In the experiments described below, we explore the 
effect of poly-L-aspartic acid (PA) on the structure of 
CaOx crystals grown by spontaneous nucleation in ionic 
solution at conditions of pH and ionic strength typical of 
normal urine samples. The effect of PA on CaOx crys-
tal structure is examined as a function of supersaturation 
(SS) and calcium:oxalate (Ca:Ox) ratio in order to char-
acteriz.e the phase diagram for this precipitation. PA has 
been shown to be an effective kinetic inhibitor of CaOx 
crystallization [11, 24), and specifically should be a con-
venient, inexpensive model for osteopontin. Due to the 
dependence of nucleation rate on SS, the effective num-
ber of growing particles should increase with SS, and 
hence, the inhibitor requirement should also increase. 
The second independent parameter of Ca: Ox ratio has 
been infrequently studied in vitro, but it will certainly in-
fluence surface charge densities of crystals and polyelec-
trolytes and, therefore, their interaction. Most experi-
ments have been done under either equimolar conditions 
or fixed non-stoichiometric ratios and do not elucidate 
the dependence on Ca:Ox ratio. Normal human urine 
has a significant excess of Ca ion with a Ca:Ox ratio in 
the range of 6: 1 to 10: 1 [ 17). An even wider range of 
ratios is seen when pathologic states are included. 
Materials and Methods 
All chemicals were reagent grade and were used 
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without further purification. Solutions were prepared in 
water that was deioni:zed and filtered using the Nanopure 
system (Barnstead, Div. Sybron, Boston, MA). Crystals 
were grown in an ionic buffer solution of 0.15 M NaCl 
and 0.01 M HEPES (N-[2-Hydroxy]piperazine-N'-[2-
ethanesulfonic acid]) titrated to pH 7.5 with HCI. 
Solutions were prepared by volumetric additions of stock 
solutions to the appropriate quantity of deioni:zed water. 
All solutions were equilibrated to room temperature 
before mixing. Calcium ion was added by volumetric 
addition of a 10 mM CaCl2 stock solution. Oxalate ion 
was introduced from a 10 mM stock solution of 
N½Ci04. Typically, solutions were prepared to a total 
volume of 10 ml in a new glass scintillation vial. Before 
Ox ion addition, all other components, including any 
inhibitors, were added to the container and thoroughly 
mixed. Immediately following the addition of oxalate 
ion, the solutions were shaken vigorously for iO to 15 
seconds, and the precipitation was then allowed to occur 
at room temperature (295 K ± 3 K) under quiescent 
conditions. {Authors' note: Subsequent experiments 
have shown a dependence of the concentration of PA 
required to obtain COD on the lot of glass vials used for 
the experiment. This presumably resulted from differ-
ences in PA surface adsorption to the different glass 
vials, but we could eliminate this effect by pretreating 
the vials with Gel Slick® (AT Biochem, Malvern, PA)}. 
PA (Sigma, St. Louis, MO; molecular weight: 15 
kDa) was added from a 0.138 mg/ml (9.23 µmolar) 
stock solution again by volumetric addition. The volume 
of inhibitor solution added was in excess of the 10 ml 
total volume described above, and ion and inhibitor con-
centrations were corrected for this additional dilution. 
The maximum change was 6.6% at the largest PA lev-
els; however, for all but a few samples, this change was 
less than 3 % . Aspartic acid monomer (Na salt; Sigma) 
was prepared as an aqueous stock solution at the same 
mass concentration as PA and added in the same way. 
Samples were generally allowed to precipitate for 
more than 3 hours or until an appreciable crystal mass 
was observed, before examining the resulting crystals. 
At the lowest supersaturations, the precipitations re-
quired 1 to 2 days before satisfying the latter require-
ment. No effort was made to verify the completeness of 
the precipitation, but no difference was observed mor-
phologically between crystals formed early in the precip-
itation reaction and those formed later, at several condi-
tions. At the highest supersaturations, > 15, there was 
visible crystal mass within one minute after addition of 
Ox to the solution. Results for these conditions have 
been included below for completeness, but we are con-
cerned that the results for those conditions may have 
been influenced by locally high concentrations of rea-
gents, because of the limitations of mixing technique. 
Calcium oxalate crystallized with polyaspartate 
Crystals were isolated from solution by filtering 
through PCTE (track-etched polycarbonate) filters (5.0 
µm pore size, Poretics, Livermore, CA) in Swinney fil-
ter holders (Millipore, Bedford, MA). Filters were then 
placed on a microscope slide with a drop of solution and 
covered with a cover slide. Optical microscopy was 
performed immediately on all samples using a Nikon 
Optiphot-2 microscope (Nikon, Inc., Instrument Group, 
Melville, NY), and photographs were taken of selected 
samples with the attached camera system (Olympus Au-
tomatic Photomicrographic System PM-lOADS, Olym-
pus Optical, Ltd., Tokyo, Japan). An effort was made 
to examme the crystals over the entire area of each slide 
by manually raster scanning the field because the relative 
quantities of COM and COD crystals sometimes varied 
from one field to another. At the lowest supersatura-
tions, hundreds to thousands of crystals were seen in 
each slide. Samples at supersaturations of 7 to 10 
formed tens of thousands of crystals. For high supersat-
uration conditions, where an even larger crystal mass 
was formed, dense piles of crystals were frequently 
seen. The edges of such piles were examined thorough-
ly, but no effort was made to disperse these piles. 
Crystal mass determinations were made on some 
samples by filtering multiple, identically prepared sam-
ples and weighing the recovered crystal mass on an XA-
200DS analytical balance (Fisher Scientific, Pittsburgh, 
PA). Filters used were the 5.0 µm PCTE filters as 
above and 0.1 µm PCTE filters from the same manufac-
turer. After filtering the crystals and removing excess 
solvent by pushing a small quantity of air through the 
pre-weighed filters, the samples were further dried at 
323 K for one hour. No change in crystal morphology 
was noted with this drying protocol. Filter masses were 
1.66 mg (standard deviation, SD, 0.05) and 0.89 mg 
(SD 0.05) for the 5.0 µm and 0.1 µm filters, respective-
ly. Standard deviation (SD) for repeated mass determi-
nation of a single filter was also 0.05 mg. 
Ca ion concentration was determined with a calcium 
selective electrode model F2112Ca with calomel refer-
ence electrode K401 and appropriate meter PHM82 
(Radiometer A/S, Copenhagen, Denmark), and readings 
were recorded with a chart recorder. The system was 
calibrated with CaC12 solutions in the same buffer media 
(0.15 M NaCl and 0.01 M HEPES) prepared by volu-
metric additions. Particle growth kinetics were deter-
mined by using a model LS-5 (Perkin-Elmer, Oak 
Brook, IL) fluorescence spectrometer as a fixed angle 
scattering photometer by setting both emission and ex -
citation wavelengths to 500 nm and both slit widths to 5 
nm. Polystyrene cuvettes were used as sample cells. 
The scattered intensity was minimal from the original 
solutions, but rose rapidly with the appearance of crys-
tals in the sample. No attempt bas been made to quanti-
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tate this response in terms of particle number, size and 
distribution since the purpose of this experiment was to 
test for changes in the kinetics, i.e., nucleation and 
growth, of CaOx crystals. Again, time dependent sig-
nals were recorded with a chart recorder and digitized 
for presentation. 
X-ray powder diffraction was performed on thirty 
samples selected from various solution compositions at 
the National VA Crystal Identification Laboratory (Mil-
waukee, WI) to confirm the morphological identifica-
tion. In general, microscopic examination of these sam-
ples was a much more sensitive measure of composition 
than powder diffraction, allowing the identification of 
even a single crystal of the non-dominant structure in a 
field of thousands of the other type. In fact, no condi-
tions were found to be purely one crystalline structure or 
the other in microscopic examination. However, sam-
ples were considered to be pure in one structure if only 
a few crystals, representing a trivial number fraction, of 
the other structure were seen after examining the entire 
area of the slide. Powder diffraction results were used 
for samples demonstrating an ambiguous morphology 
(e.g., equimolar with SS = 15.6 and with 616 nM PA). 
This protocol was used throughout the experiment. 
We calculated the SS by the following definition: 
SS = {([Ca][Ox])/([Ca1o(Ox]o)}0.5 
where [Ca] and [Ox] represent the initial ion concentra-
tions for calciu,m and oxalate ions, respectively, in a 
given solution and [Ca]0 and [Ox]0 are the concentra-
tions of those ions at equilibrium (calculated to be 0.15 
mM for the temperature and buffer conditions above, 
using the speciation program EQUIL2 (201). This quan-
tity is more properly defined as the above ratio of activi-
ties; however, the solution ionic strength and pH condi-
tions are dominated by the NaCl and HEPES buffer 
components, with relatively small variations in the Ca 
and Ox concentrations. Consequently, the correction 
factors to calculate ionic activities are expected to cancel 
with a very small error. 
Results 
In Figures 1, 2 and 3, examples of representative 
fields for three samples are shown to illustrate the typi-
cal crystal habits seen for COM rich (Fig. 1, from a so-
lution with a Ca:Ox ratio of 10: 1, at SS = 10.5 with no 
PA added), COD rich (Fig. 2, from an equimolar sam-
ple at SS = 9.9 with 123 nM PA added) samples, and 
mixed fields (Fig. 3, from an equimolar sample at SS = 
13.2 with 123 nM PA added). All three micrographs 
were taken from fields where the crystals had washed 
off the surface of the filter for clarity of presentation. 
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Figure 1. Optical micrograph of COM morphology typ-
ical of crystals grown with no PA added. This sample 
resulted from the precipitation from 5.0 mM Ca with 
0.5 mM Ox and no PA added (SS = 10.5). 
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Figure 2. Optical micrograph of COD morphology typ-
ical of crystals grown with a large concentration of PA. 
This sample resulted from the precipitation of 1.5 mM 
Ca with 1.5 mM Ox and 123 nM PA (SS = 9.9). 
No differences were discernible between crystals that 
remained on the filter and those that washed off. 
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Figure 3. Optical micrograph of mixture of COM and 
COD morphologies formed simultaneously in the pres-
ence of intermediate concentrations of PA. This sample 
resulted from the precipitation of 2.0 mM Ca with 2.0 
mM Ox and 123 nM PA (SS = 13.2). The "starfish" 
geometry of COD is seen near the center of Figure 3, 
and it has a maximum linear dimension of about 15 µm. 
Note that this condition was at the same quantity of add-
ed PA as shown in Figure 2, but at this higher SS, the 
PA concentration was no longer sufficient to lead to 
complete COD formation. 
--------------------------------·-
The plate-like forms seen in Figure 1 were charac-
teristic of the COM crystals formed under most condi-
tions, although, at high supersaturations, the crystals be-
came somewhat rounded at the ends and appeared to be 
a bit thicker with a dimpling of the central portion sug-
gestive of a "canoe" shape, as described previously [10]. 
Several crystals in Figure 3 show these characteristics. 
The long axis of these crystals was typically in the range 
of 5 to 20 µm. In many samples, aggregates of plates 
were observed. Morphologic characterization was con-
firmed by X-ray powder diffraction for any variations 
observed. While some variation of COM crystal mor-
phology was observed at different conditions, COD 
morphology was always as seen in Figures 2 and 3. 
In Figure 2, the octahedral crystals characteristic of 
COD are seen. Again, these crystals were usually in the 
sire range of 5 to 20 µm in maximum dimension. In 
Figure 3, not only are COM and COD forms seen, but 
also a distorted octahedral form that looks like a four-
armed starfish. These were demonstrated to be COD 
structures, likely a resultant from twinning, and were 
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Figure 4. Crystal composition phase diagram for equi-
molar CaOx solutions, with the supersaturation plotted 
along the abscissa and the concentration of PA on the 
ordinate. The presence of COM crystals is indicated by 
a filled square, while COD is indicated by an open cir-
cle. The "starfish" COD geometry is represented by an 
eight-pointed star. Superimposed symbols at many inter-
mediate conditions indicate the formation of both COM 
and COD structures simultaneously at those conditions. 
most commonly observed in samples with intermediate 
amounts of PA added and at higher SS. These crystal-
line forms tended to be slightly larger than the classic 
COD forms, ranging up to about 25 µm in maximum 
dimension, and they were frequently the first COD 
forms seen with increasing concentration of PA. 
There is a population of crystals seen in all three ex-
amples above that are too small to be adequately charac-
terized by optical microscopy and clearly much smaller 
than the 5.0 µm pore size of the filter. Since the par-
ticle size distributions were inherently broad, these were 
felt to be representative of the compositional distribution 
of the larger crystals seen. The small crystals appeared 
to be a very small fraction of the total crystal mass by 
optical microscopy, although these were collected on a 
5.0 µm filter. To better gauge the significance of this 
population of crystals in terms of weight fraction of the 
total sample, a comparison was made between the crys-
tal mass isolated with a 5.0 µm filter versus that obtain-
ed with a 0.1 µm filter. We observed 1. 15 mg (SD 
0.06) recovered with a 5.0 µm filter and 1.18 mg (SD 
0.10) recovered with a 0.1 µm filter from equimolar cal-
cium oxalate solutions at SS = 9. 9 with 62 nM PA at 27 
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Figure 5. Crystal composition phase diagram for solu-
tions with a ratio of Ca: Ox of 10: 1 plotted as in Figure 
4. Filled square: COM crystals; open circle: COD 
crystals; eight-pointed star: "starfish" COD geometry. 
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hours (recovered crystal mass was the same at 4 hours). 
No significant difference was observed. Given the un-
certainties in weighing, we placed the unrecovered 
weight fraction with a 5.0 µm filter at < 0.05. It is 
important to note that X-ray powder diffraction data did 
not show evidence of unrecognized crystal structures 
(either COD in a sample felt to be pure COM, or vice 
versa), suggesting that these small crystals were at least 
the same structure as the larger crystals, if not a trivial 
weight fraction of the total sample. In either case, fur-
ther characterization of them would not affect our gener-
al conclusions, so further evaluation (e.g., by scanning 
electron microscopy) was not pursued. 
The crystal composition phase diagram for equimo-
lar Ca and Ox is shown in Figure 4 as a function of SS 
and [PA]. COM (filled squares) was formed exclusively 
in the absence of PA. At sufficiently large [PA], at 
most SS (i .e. , > 100 nM PA at SS = 10), COD (open 
circles) was formed exclusively. The symbols were cho-
sen in a manner to highlight the concentration of PA 
above which COM was no longer observed. At low SS, 
i.e. , 6 or below, the points are too close I y spaced on 
this scale to show it clearly, but the same qualitative pic-
ture was demonstrated. With no added PA, the samples 
were pure COM, but pure COD was obtained by the ad-
dition of9.2 nM PA at SS of 4 and 18 nM PA at SS of 
5. 3. A similar result was obtained by reducing the SS 
at constant added PA, as illustrated in Figures 2 and 3. 
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Figure 6. Crystal composition phase diagram for solu-
tions at constant SS of 11.58 ± 0.05, but with varying 
ratios of Ca:Ox. Ca concentration is plotted along the 
abscissa, with the matching Ca:Ox ratio listed at the top 
of each data column. The PA concentration is plotted 
on the ordinate. Filled square: COM crystals; open cir-
cle: COD crystals; eight-pointed star: "starfish" COD 
geometry. 
The highest SS data apparently deviate from the pattern, 
but this must be interpreted cautiously, given the kinetic 
limitations of our experimental desiga, as described 
above. The increase in the [PA] required to obtain 
COD with increasing SS was dramatic. 
At intermediate [PA], crystals of both types were 
observed, and these regions are identifiable by the super-
posed symbols for various crystalline forms. The star-
fish form of COD (eight-pointed character) was also 
found at high SS and intermediate amounts of PA (i .e. , 
SS > 10 and 100 nM PA). The relative ratio of COD 
to COM was seen to increase systematically with the 
amount of PA added. This behavior was also demon-
strated at the highest SS, even though a condition show-
ing pure COD was not clearly identified. Although no 
effort was made to quaotitate the relative amount of 
COD as a function of [PA], clearly, the transition from 
favoring one crystalline form to favoring the other was 
a gradual one, indicating a proportional response of 
crystal structure to [PA]. The angulation of the data 
toward the ordinate in the columns of nearly constant 
supersaturation resulted from correcting for the dilution 
from adding the PA stock solution. 
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This general pattern was reproduced at other Ca:Ox 
ratios, although as this ratio increased, the amount of 
PA required to obtain pure COD decreased. Figure 5 
shows the comparable crystal composition phase diagram 
at a Ca:Ox ratio of 10: 1. The same symbolic represen-
tation of data has been used to facilitate comparison of 
data. One clear difference at higher Ca:Ox ratios was 
the presence of significant, though still small, amounts 
of COD crystals in samples with no PA added, consis-
tent with the reduced need for PA to obtain COD. This 
was more prominent at higher SS. 
Figure 6 shows the dependence of crystal structure 
on the Ca: Ox ratio and the amount of PA added for a SS 
of 11.58 ± 0.05, using the same symbolic representa-
tions as above. The data are shown according to the in-
terpretation by optical microscopy. The sample at 0.55 
mM Ca and 360 nM PA had a significant, minor frac-
tion of the crystal mass with ambiguous morphology. 
Subsequent X-ray powder diffraction demonstrated that 
COM was present in this sample, so the upward curva-
ture suggested by this diagram at low Ca:Ox ratios , i.e. , 
1 or less, is certainly greater than that indicated in Fig-
ure 6. While our experiment emphasized the behavior 
under normal urine conditions, which is fully included 
in the range of Ca: Ox ratios sampled here, the depend-
ence on Ca:Ox ratio is strongest at the lower extreme of 
the data range. At the higher extreme, the amount of 
PA required for formation of COD is apparently 
independent of Ca:Ox ratio. 
The effect of monomeric L-aspartic acid was also 
examined at equimolar conditions and SS = 6.7. Crys-
tals were grown in the presence of 5 µglml and 10 
µglml of added aspartic acid monomer (corresponding 
on a weight basis to the 0.33 and 0.66 µmolar PA solu-
tions) , and the crystals obtained were indistinguishable 
from those grown in the absence of any added inhibitors; 
i.e. , pure COM. With the equivalent mass of PA, COD 
was found at either of these concentrations (see Fig. 4) . 
Aspartic acid monomer may be an inhibitor at higher 
concentrations, similar to citrate and pyrophosphate ani-
ons, but it is clearly less effective than PA in this re-
gard. Evidently, the polymeric nature of the inhibitor is 
a critical characteristic for the effects on crystal structure 
demonstrated above. 
To better understand the mechanism of the PA ef-
fect on CaOx crystallization, two additional experiments 
were performed. A calcium selective electrode was used 
to test for a decrease in the Ca ion activity with addition 
of PA. The electrode was calibrated over the range of 
0.1 mM to 10 mM Ca ion with a nearly linear increase 
in voltage output per unit change in log([Ca]); slope = 
30 mV/decade and intercept= 43 mV with [Ca] ion ex-
pressed in mM units. No difference was detectable in 
the [Ca] ion at 1.0 mM between the presence or absence 
Calcium oxalate crystallized with polyaspartate 
of 616 nM PA. The minimum detectable change was 
expected to be 0.5 mV based on the variation in record-
ed potentials for independently prepared solutions, or 
about a 4% change in the [Ca]. The [PA] corresponds 
to 0.068 mM aspartic acid monomer units, so a detect-
able change even at this largest [PA] tested would re-
quire condensation of Ca ion on the chain past neutrali-
ty. Clearly, for the quantities of PA used in this study, 
there was no appreciable effect on the Ca ion activity by 
the addition of PA. 
In a second experiment, the influence of [PA] on the 
kinetics of COD crystallization was probed. Equimolar 
solutions at 1.5 mM Ca and Ox (SS = 9.9) were pre-
pared at four quantities of added PA: 0 nM, 123 nM, 
246 nM and 492 nM. COM was formed with no added 
PA, while the other three conditions lead to COD; the 
123 nM condition was near to the lower boundary for 
complete COD formation. The time dependence of the 
scattered intensity is shown in Figure 7 for four repre-
sentative precipitations. Data were not obtained during 
the first 60 seconds due to mixing and solution transfer 
issues. There was a clear progression toward longer lag 
times with increasing [PA], and there appeared to be a 
decrease in the initial slope. The increasing lag times 
indicate an increasing delay in or slowing of nucleation. 
The changes in the initial slope are likely related to dif-
ferences in growth rates, but this conclusion is tenuous 
given the known dependence of scattered intensity on the 
number, size and shape of the growing crystals, and 
none of these parameters were measured independently. 
Discus.sion 
The data presented above do not elucidate the mech-
anism of the interaction of PA with the growing crystal 
mass that leads to the preferential formation of COD, 
but several significant clues are evident. 
There is a dramatic increase in PA requirement for 
COD formation with increasing SS, implying a relation-
ship between the number of nuclei and the amount of 
polymer added. Unfortunately, quantitative data for the 
number of nuclei formed under the various conditions 
tested in this study are not yet available to allow a direct 
comparison of the increase in PA with the increase in 
number of crystal nuclei per unit volume. The gradual 
transition from predominantly COM to predominantly 
COD with increasing PA at a constant SS also suggests 
a relationship between the polymer concentration and the 
number of growing crystals or nuclei. The proportional 
response to PA implies that PA must somehow be con-
sumed in this process, either through binding to a non-
propagating COM nucleus or adherence to a COD crys-
tal. Other reported inhibitors also demonstrate a propor-
tional response [16]. 
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Figure 7. The scattered intensity as a function of time 
from solutions of 1.5 mM Ca with 1.5 mM Ox and var-
ying amounts of added PA is plotted. Filled circle: no 
added PA (formed COM); filled triangle: 123 nM PA 
(formed COD); open diamond: 246 nM PA (formed 
COD); filled square: 492 nM PA (formed COD). Data 
for the first 60 seconds was not obtained due to limita-
tions in our ability to mix the solutions and transfer them 
to the instrument. Scattering was measured in a fluores-
cence spectrometer at a wavelength of 500 nm. 
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There was no evidence for conversion of one struc-
ture to the other, in particular COM to COD, in our ob-
servations. No difference was noticeable in the crystal 
composition (COM:COD ratio) between samples crystal-
lized for several hours and samples crystallized for 
several days, although a transition from COD (a meta-
stable structure) to COM might occur on a longer time 
scale or under other conditions. Tested in a second 
way, if the PA addition was made after Ox was added 
to initiate the precipitation at a condition that would nor-
mally yield pure COD (e.g., equimolar at 1.5 mM Ca 
and Ox; SS = 9.9 with 308 nM PA), a mixture of COM 
and COD was obtained, providing that the addition of 
PA was delayed until some crystal mass had formed in 
the sample. Evidently, PA does not transform the COM 
structure to COD, but it does prevent further develop-
ment of COM, despite the presence of COM "seed" 
crystals in the precipitating solution. Others have 
proposed that COD forms first and is then converted to 
COM [19], but we saw no evidence to support this inter-
pretation in our experiments. 
We favor the interpretation that the presence of PA 
inhibits the growth of both COM and COD, but is more 
effective against COM formation, so that COD becomes 
the favored product for kinetic reasons. The study [16] 
J.A. Wesson and E. Worcester 
cited above reported that kinetic inhibitors of COM fa-
vor COD formation, including urinary solutes, heparin, 
RNA and small molecule inhibitors, such as citrate and 
pyrophosphate. Another study [9] demonstrated that a 
micellar anionic surfactant also inhibited crystal forma-
tion and favored the formation of COD in a spontaneous 
nucleation experiment, while non-ionic and cationic mi-
celles did not affect the crystal structure, although they 
did influence crystallization kinetics (non-ionic micelles 
facilitating and cationic micelles inhibiting crystalliza-
tion). It is unlikely that these disparate compounds and 
PA all manage to form a unique template surface to 
stimulate the formation of the less favored COD struc-
ture. However, they are all anionic (or polyanionic), 
and could be expected to condense on a cationic growing 
crystal surface in a similar manner, possibly inhibiting 
the growth of that surface. The relatively greater effec-
tiveness of the polyanions would be consistent with their 
inherently greater affinity through cooperativity for an 
oppositely charged surface in this model, and with the 
possibility that binding of one macromolecular structure 
might cover the entire growing surface of an incipient 
nucleus. Why PA and other inhibitors would be more 
effective against COM than COD is not evident at this 
time, but it must certainly depend on the surface charac-
teristics of growing crystal faces. 
An additional inference can be made from the be-
haviors observed as a function of Ca:Ox ratio, with re-
spect to the relative merits of the template and inhibitor 
models. Template growth should be favored by low Ca 
(high Ox) conditions. If PA was acting as a template, 
the first layer of ion condensation must be Ca. Since 
the template generated structure (COD) must compete 
for available Ca (and Ox) with spontaneous nucleation 
which leads to COM, the natural ionic association of Ca 
with PA could create locally high concentrations of Ca, 
fostering template stimulated crystal formation at the ex-
pense of spontaneous nucleation (COM formation). On 
the other hand, a large excess of Ca ion could saturate 
the template sites, while still maintaining a large solution 
Ca concentration to drive spontaneous nucleation and 
COM formation, predicting an increased requirement for 
PA with increasing Ca:Ox ratio. Of course, PA must 
still be serving as an inhibitor of both COD and COM 
growth at the same time it is serving as a template. 
Conversely, in the inhibitor model, PA must compete 
for the appropriate growing crystal face with other ani-
ons in solution (monomeric and polymeric), and its in-
hibitory effect should be reduced in the presence of 
sufficiently high [Ox], through a competitive equilibrium 
process. The cooperative binding advantage of PA is 
proportional to the number of monomer units per chain, 
but each carboxylic acid end group should have 
essentially the same affinity for the charge sites on 
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crystal nuclei, whether from PA or Ox. The high Ox 
conditions reported here correspond to approximately a 
100-fold excess of Ox to aspartic acid monomer units at 
the highest [PA] used. Low Ox (high Ca) conditions 
should then facilitate the effect of PA on crystal 
structure. Our data, in Figure 6, clearly agree with the 
inhibitor model. This is also consistent with in vivo data 
showing that high [Ca] favors COD in crystalluria [6]. 
We conclude that the inhibitor model of interaction 
is much more consistent with the available data. Since 
COD can spontaneously form in solution at least at high 
Ca concentrations, the differential change in the growth 
rate of COM relative to COD may not need to be very 
large to lead to preferential COD formation. However, 
we cannot exclude the possibility that the polymer in-
duces a change in the structure of the ionic cluster corre-
sponding to the incipient crystal nucleus that allows it to 
grow as a COD crystal, instead of COM, but this hy-
potheses fits less well with our data and with the pub-
lished effects of other inhibitor molecules. Other mech-
anisms may also be possible. The implications for kid-
ney stone disease may be significant, if subsequent ex-
periments show a preferential formation of COD in the 
presence of normal urinary macromolecules-like uropon-
tin and a reduced affinity of COD for renal tubule cells, 
compared to COM. 
In summary, we have shown that PA, a model poly-
anion inhibitor of calcium oxalate crystal growth, favors 
the formation of COD in supersaturated solutions of cal-
cium and oxalate at pH = 7.5 and 0.15 M NaCl. The 
concentration of PA required to cause this change in pre-
ferred crystal structure increases with increasing super-
saturation and decreases with increasing Ca:Ox ratio, in 
a nonlinear manner in both instances. Also, the forma-
tion of COD is inherently favored by high Ca:Ox ratios. 
The transition of crystalline forms is a smoothly varying 
function of PA concentration, implying a stoichiometric 
relationship to COM (or COD) crystal mass. PA has 
also been shown to inhibit the kinetics of COD crystal 
nucleation and growth. The effect of PA on the crystal 
structure depends on the polymeric nature of the mole-
cule, as monomeric aspartic acid has no effect on crystal 
structure or morphology at similar mass concentrations. 
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Discussion with Reviewers 
L. Addacli: The "starfish" form of COD is treated as 
a separate and important observation. This is, in my 
opinion, just an effect of twinning that has been ob-
served repeatedly in the literature of COD and is a very 
common event in crystal growth. 
G.H. Nancollas: The X-ray powder diffraction of the 
"starfish" crystallites will be important. 
Authors: We agree with the description of this "star-
fish" structure as a twinned COD crystal, but we have 
not seen any published examples or description of condi-
tions favoring its formation. We deduced the crystal 
structure for this form by the following finding. We ex-
amined a sample (equimolar; SS = 13.2, 123 nM PA) 
which was a mixture of "starfish" and normal COM 
forms (no apparent normal COD forms) by microscopy; 
we found the sample to be a mixture of COM and COD 
by powder diffraction. 
H.-G. Tiselius: The quantitation of the relative occur-
rence of COD and COM crystals in the precipitate is of 
J.A. Wesson and E. Worcester 
crucial importance and in view of the great number of 
crystals, particularly at high levels of SS, it can be 
assumed that this is not easy. A detailed description of 
how the authors coped with this problem is desirable. 
G.H. Nancollas: Did the authors use the X-ray diffrac-
tion technique in order to determine the exact percentage 
of COM and COD? This can easily be achieved with 
appropriate attention to standardization. This is particu-
larly true in interpreting the data shown in Figures 4 and 
5; it should be possible to quantify the amounts of dif-
ferent hydrates formed as a function of PA concen-
tration. 
L.C. Cao: The designed and used model system in vi-
tro is semi-quantitative since neither light microscopy or 
X-ray powder diffraction can give an accurate result 
about COM/COD ratio. 
Authors: We specifically avoided the question of nu-
merical quantitation of the fractions of COM and COD 
in these samples because of the difficulty in obtaining 
these data. Dr. Neil Mandel, who is head of the Nation-
al VA Crystal Identification Center in Milwaukee and 
who donated the X-ray powder diffraction analyses to 
our work, advised us that the use of powder diffraction 
for quantitative analysis was possible, but extremely dif-
ficult, typically yielding data of limited precision. This 
comment is echoed by Dr. Cao above, while Profs. 
Nancollas and Tiselius are advocating powder diffraction 
for this purpose. We defer any conclusions of the valid-
ity of this analytical method to these people since we are 
not experts in this technique. Digital image analysis was 
a second possibility, but unfortunately, it is not available 
to us here. We are currently investigating the use of 
Fourier-transform infrared spectroscopy (FTIR) for bulk 
compositional analysis of calcium oxalate crystals, but it 
too has limitations that we have not yet completely re-
solved. Consequently, we emphasize the point that the 
addition of polyaspartate to the precipitation leads to a 
structural change in the crystal formed. We also note 
that the response to polyaspartate is a gradual one with 
the addition of increasing amounts of polymer. Both of 
these points are unambiguously made with our experi-
ments. While we did not determine the functional de-
pendence of crystal composition on polyaspartic acid ad-
dition, Martin et al. [16) showed essentially a linear 
increase in COD with added inhibitors (both monomeric 
and polymeric), and we anticipate a similar behavior for 
our inhibitor based on our visual impression. 
H.-G. Tiselius: In these experiments, did you, under 
any conditions, observe crystals of calcium oxalate trihy-
drate (COT)? 
Authors: We did not find COT at any of the conditions 
reported here. We have grown COT in our laboratory, 
but only when stirring the samples with a magnetic stir-
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ring apparatus, with little or no inhibitor present. 
G.H. Nancollas: One has to be careful in identifying 
phases by morphology. The crystals in Figure 1 appear 
to be significantly twinned. Did the authors measure the 
particle size distribution of the precipitated products 
since some appear to be more aggregated than others? 
Aggregation may well be a significant factor in the path-
ological formation of calcium oxalate deposits. 
Authors: We agree that aggregation may be an impor-
tant physiological issue, and we certainly see evidence 
of it in our in vitro studies. However, we did not spe-
cifically follow this parameter since our focus was on 
crystal structure in this study. When the crystal mor-
phology did not allow for a straightforward identification 
of the structure (which occurred in very few cases in our 
experiments), we used powder diffraction as our abso-
lute identification method. 
G.H. Nancollas: It is important to recognize that the 
crystal surface potential (zeta) will be sensitive both to 
the adsorption of excess calcium ions and the adsorption 
of PA. These will be opposing effects on the zeta po-
tential and also on the degree of aggregation. The fact 
that monomeric aspartic acid has no influence on the 
phase formed again suggests that the surface potential 
may be an important parameter to monitor. 
Authors: We agree that the surface zeta potential is 
likely a critical parameter in determining the crystal 
interaction. These experiments would probably help 
elucidate the nature of the polymer-crystal interaction, 
but they are beyond the scope of this study. 
S.R. Khan: Have you examined the impact of osteo-
pontin on calcium oxalate crystal formation in vitro and 
compared it with the effect of PA? 
Authors: We are currently conducting experiments to 
examine the influence of several macromolecules found 
in urine, including osteopontin, on the crystal structure 
of calcium oxalate crystals formed under similar condi-
tions to those reported here. Osteopontin also affects the 
crystal structure in a similar manner at physiologically 
relevant concentrations. These experiments will be 
described in detail in a subsequent publication. 
